Gain Therapeutics updates shareholders on the advancement of GT-02287 for Parkinson's disease, highlighting key clinical trial milestones and funding support. Gain Therapeutics, Inc. has announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results